{"id":9556,"date":"2025-09-17T00:27:02","date_gmt":"2025-09-16T22:27:02","guid":{"rendered":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/"},"modified":"2025-09-17T00:27:03","modified_gmt":"2025-09-16T22:27:03","slug":"letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique","status":"publish","type":"post","link":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/","title":{"rendered":"L&rsquo;\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique"},"content":{"rendered":"<div>\n<div class=\"article-gallery lightGallery\">\n<div data-thumb=\"https:\/\/scx1.b-cdn.net\/csz\/news\/tmb\/2025\/new-antibody-may-slow.jpg\" data-src=\"https:\/\/scx2.b-cdn.net\/gfx\/news\/2025\/new-antibody-may-slow.jpg\" data-sub-html=\"Credit: &lt;i&gt;Journal of Clinical Investigation&lt;\/i&gt; (2025). DOI: 10.1172\/JCI190286\">\n<figure class=\"article-img\">\n<\/figure><\/div>\n<\/div>\n<p>La maladie r\u00e9nale chronique est un probl\u00e8me de sant\u00e9 croissant affectant environ 1 Su\u00e9dois sur 10. La condition implique une baisse progressive de la fonction r\u00e9nale, ce qui peut entra\u00eener le besoin de dialyse ou de transplantation.<\/p>\n<p>Une nouvelle \u00e9tude de l&rsquo;Institut Karolinska, de l&rsquo;Universit\u00e9 d&rsquo;Uppsala et de la Northwestern University montre d\u00e9sormais qu&rsquo;un anticorps exp\u00e9rimental peut prot\u00e9ger les vaisseaux sanguins du rein et r\u00e9duire les cicatrices nocives, appel\u00e9es fibrose. L&rsquo;\u0153uvre est publi\u00e9e dans le <i>Journal of Clinical Investigation<\/i>.<\/p>\n<p>Les chercheurs ont examin\u00e9 comment l&rsquo;activation d&rsquo;un r\u00e9cepteur \u00e0 la surface des vaisseaux sanguins, appel\u00e9e Tie2, influence la progression de la maladie. En utilisant un anticorps sp\u00e9cifique, ABTAA, ils ont pu stimuler TIE2 et prot\u00e9ger ainsi les vaisseaux sanguins dans le rein. L&rsquo;anticorps fonctionne en se liant \u00e0 une prot\u00e9ine qui inhibe normalement Tie2, la convertissant en activateur.<\/p>\n<p>\u00ab\u00a0En prot\u00e9geant les navires, nous avons \u00e9galement pu pr\u00e9server le microenvironnement du rein et bloquer les voies de signalisation qui stimulent la fibrose\u00a0\u00bb, explique Marie Jeansson du minist\u00e8re de la m\u00e9decine, Huddinde, l&rsquo;un des chercheurs derri\u00e8re l&rsquo;\u00e9tude.<\/p>\n<p>Les r\u00e9sultats sont bas\u00e9s sur des mod\u00e8les pr\u00e9cliniques et montrent que l&rsquo;ABTAA r\u00e9duit non seulement les dommages aux vaisseaux sanguins, mais affecte \u00e9galement d&rsquo;autres parties du rein. Une d\u00e9couverte importante est que les vaisseaux sanguins endommag\u00e9s ne se transforment pas directement en autres types de cellules, comme cela le supposait pr\u00e9c\u00e9demment. Au lieu de cela, un autre type de cellule dans le rein est influenc\u00e9 pour s\u00e9cr\u00e9ter des substances qui favorisent la fibrose. En activant TIE2, les chercheurs ont pu r\u00e9duire cette signalisation.<\/p>\n<p>\u00ab\u00a0Nos r\u00e9sultats sugg\u00e8rent que l&rsquo;activation de Tie2 avec ABTAA pourrait \u00eatre transform\u00e9e en une nouvelle strat\u00e9gie de traitement pour une maladie r\u00e9nale chronique. Il s&rsquo;agit d&rsquo;un domaine o\u00f9 les options de traitement sont encore tr\u00e8s limit\u00e9es, et les progr\u00e8s pourraient \u00e9ventuellement avoir un impact majeur pour les patients\u00a0\u00bb, explique Jeansson.<\/p>\n<p>L&rsquo;\u00e9tude fournit de nouvelles informations sur la fa\u00e7on dont la fibrose se d\u00e9veloppe dans le rein et met en \u00e9vidence le r\u00f4le des vaisseaux sanguins en tant que nouvelle cible potentielle pour le traitement. La prochaine \u00e9tape consistera \u00e0 d\u00e9terminer si les r\u00e9sultats peuvent \u00eatre traduits en humains.<\/p>\n<p>                                        <!-- print only --><\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>La maladie r\u00e9nale chronique est un probl\u00e8me de sant\u00e9 croissant affectant environ 1 Su\u00e9dois sur<\/p>\n","protected":false},"author":1,"featured_media":9557,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86],"tags":[2005,250,1148,44,6686,654,49,1346,248,92,31,249],"class_list":["post-9556","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-les-maladies","tag-anticorps","tag-chronique","tag-constate","tag-dans","tag-experimentaux","tag-fibrose","tag-les","tag-letude","tag-maladie","tag-peuvent","tag-reduire","tag-renale","generate-columns","tablet-grid-50","mobile-grid-100","grid-parent","grid-50","resize-featured-image"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L&#039;\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique - RVH-Synergie.org<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L&#039;\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique - RVH-Synergie.org\" \/>\n<meta property=\"og:description\" content=\"La maladie r\u00e9nale chronique est un probl\u00e8me de sant\u00e9 croissant affectant environ 1 Su\u00e9dois sur\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/\" \/>\n<meta property=\"og:site_name\" content=\"RVH-Synergie\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-16T22:27:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-16T22:27:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1758061622_Letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"1079\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Charles Martinez\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Charles Martinez\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/\"},\"author\":{\"name\":\"Charles Martinez\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\"},\"headline\":\"L&rsquo;\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique\",\"datePublished\":\"2025-09-16T22:27:02+00:00\",\"dateModified\":\"2025-09-16T22:27:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/\"},\"wordCount\":431,\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1758061622_Letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose.jpg\",\"keywords\":[\"anticorps\",\"chronique\",\"constate\",\"dans\",\"exp\u00e9rimentaux\",\"fibrose\",\"Les\",\"L\u00e9tude\",\"maladie\",\"peuvent\",\"r\u00e9duire\",\"r\u00e9nale\"],\"articleSection\":[\"Les maladies\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/\",\"name\":\"L'\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique - RVH-Synergie.org\",\"isPartOf\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1758061622_Letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose.jpg\",\"datePublished\":\"2025-09-16T22:27:02+00:00\",\"dateModified\":\"2025-09-16T22:27:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#primaryimage\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1758061622_Letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1758061622_Letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose.jpg\",\"width\":1280,\"height\":1079,\"caption\":\"L'\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/rvh-synergie.org\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L&rsquo;\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#website\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"name\":\"RVH-Synergie.org\",\"description\":\"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.\",\"publisher\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#organization\",\"name\":\"RVH-Synergie.org\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png\",\"width\":512,\"height\":512,\"caption\":\"RVH-Synergie.org\"},\"image\":{\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560\",\"name\":\"Charles Martinez\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"contentUrl\":\"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg\",\"caption\":\"Charles Martinez\"},\"description\":\"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.\",\"sameAs\":[\"https:\/\/rvh-synergie.org\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L'\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique - RVH-Synergie.org","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/","og_locale":"fr_FR","og_type":"article","og_title":"L'\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique - RVH-Synergie.org","og_description":"La maladie r\u00e9nale chronique est un probl\u00e8me de sant\u00e9 croissant affectant environ 1 Su\u00e9dois sur","og_url":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/","og_site_name":"RVH-Synergie","article_published_time":"2025-09-16T22:27:02+00:00","article_modified_time":"2025-09-16T22:27:03+00:00","og_image":[{"width":1280,"height":1079,"url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1758061622_Letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose.jpg","type":"image\/jpeg"}],"author":"Charles Martinez","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Charles Martinez","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#article","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/"},"author":{"name":"Charles Martinez","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560"},"headline":"L&rsquo;\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique","datePublished":"2025-09-16T22:27:02+00:00","dateModified":"2025-09-16T22:27:03+00:00","mainEntityOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/"},"wordCount":431,"publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1758061622_Letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose.jpg","keywords":["anticorps","chronique","constate","dans","exp\u00e9rimentaux","fibrose","Les","L\u00e9tude","maladie","peuvent","r\u00e9duire","r\u00e9nale"],"articleSection":["Les maladies"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/","url":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/","name":"L'\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique - RVH-Synergie.org","isPartOf":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#primaryimage"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#primaryimage"},"thumbnailUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1758061622_Letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose.jpg","datePublished":"2025-09-16T22:27:02+00:00","dateModified":"2025-09-16T22:27:03+00:00","breadcrumb":{"@id":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#primaryimage","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1758061622_Letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2025\/09\/1758061622_Letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose.jpg","width":1280,"height":1079,"caption":"L'\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique"},{"@type":"BreadcrumbList","@id":"https:\/\/rvh-synergie.org\/actualites\/letude-constate-que-les-anticorps-experimentaux-peuvent-reduire-la-fibrose-dans-la-maladie-renale-chronique\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/rvh-synergie.org\/actualites\/"},{"@type":"ListItem","position":2,"name":"L&rsquo;\u00e9tude constate que les anticorps exp\u00e9rimentaux peuvent r\u00e9duire la fibrose dans la maladie r\u00e9nale chronique"}]},{"@type":"WebSite","@id":"https:\/\/rvh-synergie.org\/actualites\/#website","url":"https:\/\/rvh-synergie.org\/actualites\/","name":"RVH-Synergie.org","description":"RVH-Synergie, site ind\u00e9pendant d&#039;informations sur la prise en charge des addictions.","publisher":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rvh-synergie.org\/actualites\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/rvh-synergie.org\/actualites\/#organization","name":"RVH-Synergie.org","url":"https:\/\/rvh-synergie.org\/actualites\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/favicon.png","width":512,"height":512,"caption":"RVH-Synergie.org"},"image":{"@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/aa5ea98671fb4e8620f488a0795d2560","name":"Charles Martinez","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/rvh-synergie.org\/actualites\/#\/schema\/person\/image\/","url":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","contentUrl":"https:\/\/rvh-synergie.org\/actualites\/wp-content\/uploads\/2024\/09\/charles-martinez-scaled.jpg","caption":"Charles Martinez"},"description":"Bonjour, je m'appelle Charles Martinez, r\u00e9dacteur passionn\u00e9 pour le m\u00e9dia RVH-synergie.org, d\u00e9di\u00e9 aux addictions et aux maladies. Depuis plus de dix ans, j'explore et rapporte les histoires poignantes des individus confront\u00e9s \u00e0 ces d\u00e9fis, tout en sensibilisant le public aux traitements novateurs et aux progr\u00e8s scientifiques dans ce domaine. Mon engagement r\u00e9side dans l'espoir de cr\u00e9er une communaut\u00e9 inform\u00e9e et empathique, pr\u00eate \u00e0 soutenir ceux qui luttent contre ces \u00e9preuves.","sameAs":["https:\/\/rvh-synergie.org\/"]}]}},"_links":{"self":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/9556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/comments?post=9556"}],"version-history":[{"count":0,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/posts\/9556\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media\/9557"}],"wp:attachment":[{"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/media?parent=9556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/categories?post=9556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rvh-synergie.org\/actualites\/wp-json\/wp\/v2\/tags?post=9556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}